Nomic

About:

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

Website: https://nomic.bio

Twitter/X: nomicbio

Top Investors: Y Combinator, Creative Destruction Lab (CDL), Lux Capital, Centech, SR One

Description:

Nomic is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. They are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. They offer scientists protein profiling solutions to empower them to decide the scope and scale of their experiments.

Total Funding Amount:

$60M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2017-01-01

Contact Email:

hello(AT)nomic.bio

Founders:

Arya Tavakoli, David Juncker, Jeff Munzar, Milad Dagher

Number of Employees:

11-50

Last Funding Date:

2024-09-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai